Attention deficits are frequently reported after traumatic brain injury (TBI) and have significant consequence for the rehabilitation process as well as for subsequent education or vocational pursuits. However, controversy exists regarding the precise components of the distributed arousal and attentional system that are impaired by TBI, and the most effective treatment. Multiple neurotransmitter systems, including norepinephrine, dopamine, serotonin, and acetylcholine, are known to be affected by TBI, and uncontrolled trials of drugs which manipulate these systems are thought to be potentially beneficial. The proposed research makes use of drugs which manipulate the dopaminergic (bromocriptine) and noradrenergic (desipramine) systems, as well as those which affect both of these systems (methylphenidate), to clarify theoretical questions about the nature of attentional systems and their impairment, as well as to derive practically useful therapeutic efficacy data. Subjects with subacute or chronic TBI will be administered one of the above medications in a double-blind, placebo-controlled, cross-over design. Dependent variables will include a wide range of measures ranging from laboratory tasks focusing on single facets of the arousal and attention system, to ecologically valid complex measures of attention-related performance. A pilot group of 10 subjects will be tested initially to identify dependent variables likely to be sensitive to drug effects. A larger follow-up study will confirm the drug benefits in multivariate analysis. Additional analyses will assess the factor structure of the arousal and attention system and individual subject variables that predict impairment and response to treatment. The factor structure will also be compared to that obtained from a control sample.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS039163-04
Application #
6540172
Study Section
Mental Disorders of Aging Review Committee (MDA)
Program Officer
Michel, Mary E
Project Start
1999-05-10
Project End
2004-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
4
Fiscal Year
2002
Total Cost
$570,498
Indirect Cost
Name
Moss Rehabilitation Hospital
Department
Type
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19141
Whyte, John; Vaccaro, Monica; Grieb-Neff, Patricia et al. (2008) The effects of bromocriptine on attention deficits after traumatic brain injury: a placebo-controlled pilot study. Am J Phys Med Rehabil 87:85-99
Whyte, John; Grieb-Neff, Patricia; Gantz, Christopher et al. (2006) Measuring sustained attention after traumatic brain injury: differences in key findings from the sustained attention to response task (SART). Neuropsychologia 44:2007-14
Tripathi, P K; Trujillo, L; Cardenas, C A et al. (2006) Analysis of the variation in use-dependent inactivation of high-threshold tetrodotoxin-resistant sodium currents recorded from rat sensory neurons. Neuroscience 143:923-38
Kim, Junghoon; Whyte, John; Hart, Tessa et al. (2005) Executive function as a predictor of inattentive behavior after traumatic brain injury. J Int Neuropsychol Soc 11:434-45
Hart, Tessa; Whyte, John; Kim, Junghoon et al. (2005) Executive function and self-awareness of ""real-world"" behavior and attention deficits following traumatic brain injury. J Head Trauma Rehabil 20:333-47
Durante, P; Cardenas, C G; Whittaker, J A et al. (2004) Low-threshold L-type calcium channels in rat dopamine neurons. J Neurophysiol 91:1450-4
Whyte, John; Hart, Tessa; Vaccaro, Monica et al. (2004) Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil 83:401-20
Whyte, John (2003) Clinical trials in rehabilitation: what are the obstacles? Am J Phys Med Rehabil 82:S16-21
Whyte, John; Vaccaro, Monica; Grieb-Neff, Patricia et al. (2002) Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. J Head Trauma Rehabil 17:284-99